Industry
Nova Biomedical Adds Sample Retain Collector to BioProfile FLEX2 Cell Culture Analyzer
Nova Biomedical (Waltham, MA, USA) has added a Sample Retain Collector (SRC) for its BioProfile FLEX2 automated cell culture analyzer which measures up to 16 tests including pH, gases, metabolites, osmolality, cell density, and cell viability. More...25 Jan 2021
COVID-19 Testing Demand to Help In-Vitro Diagnostics (IVD) Market Reach USD 118.5 Billion by 2027
The global in-vitro diagnostics (IVD) market is projected to register a CAGR of 7% from 2020 to 2027 to reach USD 118.5 billion by 2027, driven mainly by the increased demand for diagnostic testing for understanding and managing infectious diseases, such as COVID-19. More...22 Jan 2021
Thermo Fisher Acquires Point-of-Care Molecular Diagnostics Provider Mesa Biotech
Thermo Fisher Scientific Inc. (Waltham, MA, USA) has entered into a definitive agreement to acquire Mesa Biotech (San Diego, CA, USA), a privately held molecular diagnostic company, for approximately USD 450 million in cash. More...20 Jan 2021
Roche Launches Digital Pathology Image Analysis Algorithms for Precision Patient Diagnosis in Breast Cancer
Roche (Basel, Switzerland) has announced the CE-IVD launch of its automated digital pathology algorithms, uPath HER2 (4B5) image analysis and uPath Dual ISH image analysis for breast cancer to help determine the best treatment strategy for each patient. More...13 Jan 2021
PerkinElmer to Acquire Oxford Immunotec Global PLC
PerkinElmer, Inc. (Waltham, MA; USA) has reached an agreement to acquire Oxford Immunotec Ltd. (Abingdon, UK) that will allow the company to grow its portfolio of advanced infectious disease testing solutions to include tuberculosis detection. More...08 Jan 2021
YHLO Helps China’s Top Ranking Hospital PUMCH to Upgrade from Traditional ELISA to CLIA Technology
Shenzhen YHLO Biotech Co., Ltd. (Shenzhen, China) has helped China’s top ranking hospital, Peking Union Medical College Hospital (PUMCH; Beijing, China), to successfully upgrade its laboratory from the traditional ELISA (enzyme-linked immunoassay) technology to CLIA (chemiluminescence immunoassay) technology. More...06 Jan 2021
COVID-19 Diagnostics Market to Surpass Revenues of USD 13 Billion in 2020
The global COVID-19 diagnostics market is expected to reach revenues of over USD 13 billion in 2020 and is projected to grow at a CAGR of around (9)% during the period 2020-2026, driven by the surging demand for rapid testing across the globe. However, once COVID-19 vaccines are released in the market, the novel coronavirus will no longer be given pandemic status and COVID-19 will become like any other normal infectious disease, thus reducing the demand for test kits in the market. More...10 Dec 2020
Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
New
Japanese Encephalitis Test
Japanese Encephalitis Virus Real Time PCR Kit
New
Pipette Calibration System
Artel PCS®
In Other News
Global Viral RNA Extraction Kit Market to Continue Being Driven by COVID-19 Pandemic
Nova Biomedical Launches New Laboratory Blood Glucose Reference Analyzer
New Monotest Diagnoses Risk of Invasive Aspergillosis
Streck Launches Rapid, Modular qPCR Instrument with Market-Leading Speed
Enzo Biochem Launches Portable Microplate Reader for Use with Its ELISA and Assay Kits
Randox and Bosch Healthcare Alliance Targets COVID-19 Testing
Mindray Hematology Solution Helps High-Volume Lab Run 2,820,000 CBC Tests Annually
2020 AACC Annual Scientific Meeting & Clinical Lab Expo to Be an All Virtual Event Due to Coronavirus Pandemic
Hologic Showcased Latest Advances at Virtual ECR Congress 2020
QIAGEN to Focus on Molecular Testing amidst Coronavirus Pandemic after Voluntary Public Takeover Offer by Thermo Fisher Falls Short
Awareness Technology Announces ChemWell RPR Analyzer - The Most Significant Innovation in Syphilis Testing in Last 30 Years
Nova Biomedical Adds PT/INR Test to Allegro Analyzer for POC Testing
Global Blood Glucose Monitoring Devices Market to Reach USD 13 Billion by 2023
Global ELISA Kits Market to Surpass USD 418.5 Billion by 2025
Thermo Fisher Scientific to Acquire QIAGEN N.V.
New AI System Performs as Well as Expert Pathologists in Identifying Prostate Cancer
Quest Diagnostics Acquires Blueprint Genetics
Nova Biomedical Launches New BioProfile FLEX2 On-Line Autosampler
Global Hematology Diagnostic Devices and Equipment Market to Reach USD 2.35 Billion by 2022
AI-based Software Analyzes Cancer Cells from Digitized Pathology Slides to Improve Diagnoses
Global Lateral Flow Immunoassay Based Rapid Test Market to Reach USD 8.49 Billion by 2026
Mast Group Launches MAST ISOPLEX CRE-Art Kit for Rapid Molecular Detection of Carbapenemase Producing Organisms
Global Blood Gas and Electrolyte Analyzers Market to Surpass USD 2.1 Billion by 2025
LabMedica Industry News channel reports on mergers and takeovers, on cooperative agreements and on trends in the IVD industry worldwide.
